TRPV1 and chronic asthma: Administration of capsazepine or TRPV1 siRNA attenuated airway inflammation, hypersensitiveness, as well as reduced levels of pro-inflammatory neuropeptides and oxidative stress in mouse model of chronic asthma [28,29].